CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Asymchem Laboratories Tian Jin Co Ltd Company Snapshot
Asymchem Laboratories Tian Jin Co Ltd operates in the Medicinals and botanicals sector. In addition to historical fundamental analyses, the complete report available to purchase compares Asymchem Laboratories Tian Jin Co Ltd with three other companies in this sector in CHINA : Hainan Haiyao Company Limited (2019 sales of 2.45 billion Chinese Renmimbi [US$349.43 million] of which 70% was BPC), PKU HealthCare Corp Ltd (2.51 billion Chinese Renmimbi [US$358.55 million] of which 64% was Merchandise&Material Selling), and Hunan ER-KANG Pharmaceutical Co Ltd (2.74 billion Chinese Renmimbi [US$392.17 million] of which 94% was pharmaceutic adjuvant;).

Sales Analysis. Asymchem Laboratories Tian Jin Co Ltd reported sales of 2.46 billion Chinese Renmimbi (US$351.53 million) for the year ending December of 2019. This represents an increase of 34.1% versus 2018, when the company's sales were 1.83 billion Chinese Renmimbi. Sales at Asymchem Laboratories Tian Jin Co Ltd have increased during each of the previous five years (and since 2014, sales have increased a total of 244%). Sales of Pharmaceutical Industry saw an increase of 34.2% in 2019, from 1.83 billion Chinese Renmimbi to 2.46 billion Chinese Renmimbi. Not all segments of Asymchem Laboratories Tian Jin Co Ltd experienced an increase in sales in 2019: sales of Other Business fell 97.3% to 59,469.03 Chinese Renmimbi. (However, this segment's sales were only a very small portion of the company's overall sales).
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Asymchem Laboratories Tian Jin Co Ltd
  Stock Performance Chart for Asymchem Laboratories Tian Jin Co Ltd
 
  Stock Data: Recent Stock Performance:
  Current Price (7/10/2020): 233.64
(Figures in Chinese Renmimbi)
1 Week -0.9%   13 Weeks 5.4%  
4 Weeks 26.7%   52 Weeks 133.4%  
 
Asymchem Laboratories Tian Jin Co Ltd Key Data:
  Ticker: 002821 Country: China
  Exchanges: SZN Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Medicinals & Botanicals
  2019 Sales 2,459,985,534
(Year Ending Jan 2020).
Employees: 3,840
  Currency: Chinese Renmimbi Market Cap: 54,045,549,194
  Fiscal Yr Ends: December Shares Outstanding: 231,319,762
  Share Type: Gu Closely Held Shares: 108,815,880
 
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.